Real-life cost-effectiveness of benralizumab in patients with severe asthma

Real-life cost-effectiveness of benralizumab in patients with severe asthma

Abstract Background Availability of clinically effective and cost-effective treatments for severe asthma would be beneficial to patients and national healthcare systems. The aim of this study was to evaluate clinical outcomes and healthcare expenditure after incorporating benralizumab into the stand...

Full description

Bibliographic Details
Main Authors: A. Padilla-Galo, A. J. García-Ruiz, R. Ch. Levy Abitbol, C. Olveira, F. Rivas-Ruiz, N. García-Agua Soler, M. Pérez Morales, B. Valencia Azcona, B. Tortajada-Goitia, I. Moya-Carmona, A. Levy-Naon
Format: Article
Language:English
Published: BMC 2021-05-01
Series:Respiratory Research
Subjects:
Asthma
Benralizumab
Cost-effectiveness
Economic impact
Eosinophils
Biologics
Online Access:https://doi.org/10.1186/s12931-021-01758-0

Internet

https://doi.org/10.1186/s12931-021-01758-0

Similar Items